Enora Ferron
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Enora Ferron has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Allwyn Pereira
Nantes University, CHU de Nantes, INSERM UMR 1089, TaRGeT Translational Research in Gene Therapy, F 44200 Nantes, France
2 shared publications - Christelle Retière
INSERM UMR1307, CNRS UMR6075, CRCI²NA, Team 12, Nantes, France; Etablissement Français du Sang, Nantes 44011, France
2 shared publications - Dimitri Alvarez-Dorta
Capacités, SAS, Nantes 44200, France
2 shared publications Elise Enouf
Affilogic, SAS, Nantes 44300, France
2 shared publicationsHéloïse Delépée
Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, Nantes 44000, France
2 shared publications- Karine Pavageau
Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, Nantes 44000, France
2 shared publications
Latest Publications
- 9 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Marqueurs génétiques et moléculaires de l'hétérogénéïté NK : impact sur leurs applications en hématologie
Les cellules Natural Killer (NK) sont des effecteurs cytotoxiques aux propriétés anti-leucémiques, faisant d’elles des candidats prometteurs en immunothérapie. Cependant, l’hétérogénéité intra- et inter-individuelle des cellules NK n’est pas prise en compte dans le développement de ces thérapies. Dans ces travaux, nous avons étudié l’impact des marqueurs génétiques et moléculaires de l’hétérogénéité NK. Sur une large cohorte de donneurs de sang volontaires, nous avons finement analysé les différentes sous-populations NK par cytométrie en flux. Nous montrons que la formation du répertoire NK répond à des règles génétiques impliquant les gènes polymorphes KIR et HLA, mais aussi des facteurs tels que l’âge, le sexe et le cytomégalovirus. Par ailleurs, l’analyse de l’hétérogénéité fonctionnelle des cellules NK nous a permis de définir les sous-populations NK les plus efficaces contre les leucémies lymphoïdes et myéloïdes. L’étude des interactions moléculaires entre les cellules leucémiques et les cellules NK met en évidence une dichotomie entre les leucémies lymphoïdes et myéloïdes, et souligne le rôle prédominant de l’interaction inhibitrice KIR2DL5-PVR sur les réponses NK. Ces travaux doivent aider à mieux sélectionner les donneurs de cellules souches hématopoïétiques en greffe haplo-identique et à mieux cibler les sous-populations NK qui pourraient serviront au développement d’immunothérapies.
- 9 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Marqueurs génétiques et moléculaires de l'hétérogénéïté NK : impact sur leurs applications en hématologie
Les cellules Natural Killer (NK) sont des effecteurs cytotoxiques aux propriétés anti-leucémiques, faisant d’elles des candidats prometteurs en immunothérapie. Cependant, l’hétérogénéité intra- et inter-individuelle des cellules NK n’est pas prise en compte dans le développement de ces thérapies. Dans ces travaux, nous avons étudié l’impact des marqueurs génétiques et moléculaires de l’hétérogénéité NK. Sur une large cohorte de donneurs de sang volontaires, nous avons finement analysé les différentes sous-populations NK par cytométrie en flux. Nous montrons que la formation du répertoire NK répond à des règles génétiques impliquant les gènes polymorphes KIR et HLA, mais aussi des facteurs tels que l’âge, le sexe et le cytomégalovirus. Par ailleurs, l’analyse de l’hétérogénéité fonctionnelle des cellules NK nous a permis de définir les sous-populations NK les plus efficaces contre les leucémies lymphoïdes et myéloïdes. L’étude des interactions moléculaires entre les cellules leucémiques et les cellules NK met en évidence une dichotomie entre les leucémies lymphoïdes et myéloïdes, et souligne le rôle prédominant de l’interaction inhibitrice KIR2DL5-PVR sur les réponses NK. Ces travaux doivent aider à mieux sélectionner les donneurs de cellules souches hématopoïétiques en greffe haplo-identique et à mieux cibler les sous-populations NK qui pourraient serviront au développement d’immunothérapies.
- Open Access
- 5 February 2026
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 196, 119095
Ultrafast tyrosine-based cell membrane modification via diazonium salts: A new frontier for biomedical applications
- 5 February 2026
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 196, 119095
Open AccessUltrafast tyrosine-based cell membrane modification via diazonium salts: A new frontier for biomedical applications
- Open Access
- 29 January 2026
- Published by American Society of Hematology in Blood Advances
- Vol. 10 (3) , 665-681
Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-acute myeloid leukemia activity
Haploidentical allogeneic hematopoietic stem cell transplantation (h-HSCT) is increasingly used in patients lacking an HLA-matched donor. In this context, the combination of posttransplant cyclophosphamide (PTCy) and antithymocyte globulin (ATG) effectively prevents graft-versus-host disease, but its impact on the reconstitution of peripheral blood natural killer (NK) cell subsets remains insufficiently characterized. In this study, NK cell subsets were analyzed in depth in 56 adult recipients of unmanipulated h-HSCT with PTCy and ATG. Peripheral blood samples were collected at days +30, +60, and +100 after transplant. NK cell immunophenotype and cytotoxic function were assessed using multiparameter flow cytometry with unsupervised clustering, and degranulation assays against lymphoid and myeloid targets. Data were compared with those from 200 healthy volunteers. In spite of early numerical reconstitution, NK cells exhibited an immature immunophenotype with a low expression of activation markers. Cytotoxic activity against lymphoid targets was preserved, but degranulation against acute myeloid leukemia cell lines was significantly impaired across all NK subsets, including phenotypically mature NK cells. Cytomegalovirus reactivation was associated with an expansion of memory-like NK subsets but did not enhance degranulation. Functional education via killer cell immunoglobulin–like receptors was lost by day +30 and progressively reacquired from day +60 onward, in a pattern primarily influenced by the HLA-C genotype of recipients. These results indicate that, after h-HSCT with PTCy and ATG, NK cell subsets recover in number but fail to achieve early functional competence, particularly against myeloid targets. Strategies aiming at restoring mature NK cell functions warrant prospective investigations, especially in high-risk myeloid malignancies.
- 29 January 2026
- Published by American Society of Hematology in Blood Advances
- Vol. 10 (3) , 665-681
Open AccessFunctional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-acute myeloid leukemia activity
Haploidentical allogeneic hematopoietic stem cell transplantation (h-HSCT) is increasingly used in patients lacking an HLA-matched donor. In this context, the combination of posttransplant cyclophosphamide (PTCy) and antithymocyte globulin (ATG) effectively prevents graft-versus-host disease, but its impact on the reconstitution of peripheral blood natural killer (NK) cell subsets remains insufficiently characterized. In this study, NK cell subsets were analyzed in depth in 56 adult recipients of unmanipulated h-HSCT with PTCy and ATG. Peripheral blood samples were collected at days +30, +60, and +100 after transplant. NK cell immunophenotype and cytotoxic function were assessed using multiparameter flow cytometry with unsupervised clustering, and degranulation assays against lymphoid and myeloid targets. Data were compared with those from 200 healthy volunteers. In spite of early numerical reconstitution, NK cells exhibited an immature immunophenotype with a low expression of activation markers. Cytotoxic activity against lymphoid targets was preserved, but degranulation against acute myeloid leukemia cell lines was significantly impaired across all NK subsets, including phenotypically mature NK cells. Cytomegalovirus reactivation was associated with an expansion of memory-like NK subsets but did not enhance degranulation. Functional education via killer cell immunoglobulin–like receptors was lost by day +30 and progressively reacquired from day +60 onward, in a pattern primarily influenced by the HLA-C genotype of recipients. These results indicate that, after h-HSCT with PTCy and ATG, NK cell subsets recover in number but fail to achieve early functional competence, particularly against myeloid targets. Strategies aiming at restoring mature NK cell functions warrant prospective investigations, especially in high-risk myeloid malignancies.
- Open Access
Ultrafast tyrosine-based cell membrane modification via diazonium salts: a new frontier for biomedical applications
In this study, we present an ultrafast, efficient, and broadly applicable strategy for cell membrane modification via tyrosine bioconjugation using diazonium salt derivatives. This chemical approach enables both one-step and two-step functionalization of adherent, suspension, and primary cells with diverse ligands, including imaging probes, carbohydrates, biotin, and proteins, without inducing cytotoxicity or immune activation. Membrane engineering through bioconjugation is emerging as a valuable tool in biomedical research, given the cell membrane’s central role in signaling, transport, and cell-cell interactions. Compared to traditional glyco-engineering methods that often require multiday incubations and can cause cellular stress, our approach achieves precise and high-density grafting in less than one hour, with improved reproducibility and biological compatibility. Importantly, we demonstrate that this strategy can be applied to a variety of cell types, encompassing both immortalized cell lines and primary cells, notably Peripheral Blood Mononuclear Cells (PBMCs) and human effector cells such as natural killer (NK) cells, to enhance their cytotoxic function against EGFR-positive cancer cells via surface-conjugated Nanofitin. Moreover, we show that the bioconjugated signal diminishes over time due to cell division, offering a self-limiting alternative to permanent genetic modifications such as CAR-T, thereby mitigating risks associated with overly prolonged immune activation. Finally, the feasibility of storing pre-functionalized cells at -80 °C expands the practicality of this platform for future ready-to-use applications. Together, these features make our method a compelling alternative to current technologies for applications in targeted therapy, diagnostics, and cell-based immunotherapy.
Open AccessUltrafast tyrosine-based cell membrane modification via diazonium salts: a new frontier for biomedical applications
In this study, we present an ultrafast, efficient, and broadly applicable strategy for cell membrane modification via tyrosine bioconjugation using diazonium salt derivatives. This chemical approach enables both one-step and two-step functionalization of adherent, suspension, and primary cells with diverse ligands, including imaging probes, carbohydrates, biotin, and proteins, without inducing cytotoxicity or immune activation. Membrane engineering through bioconjugation is emerging as a valuable tool in biomedical research, given the cell membrane’s central role in signaling, transport, and cell-cell interactions. Compared to traditional glyco-engineering methods that often require multiday incubations and can cause cellular stress, our approach achieves precise and high-density grafting in less than one hour, with improved reproducibility and biological compatibility. Importantly, we demonstrate that this strategy can be applied to a variety of cell types, encompassing both immortalized cell lines and primary cells, notably Peripheral Blood Mononuclear Cells (PBMCs) and human effector cells such as natural killer (NK) cells, to enhance their cytotoxic function against EGFR-positive cancer cells via surface-conjugated Nanofitin. Moreover, we show that the bioconjugated signal diminishes over time due to cell division, offering a self-limiting alternative to permanent genetic modifications such as CAR-T, thereby mitigating risks associated with overly prolonged immune activation. Finally, the feasibility of storing pre-functionalized cells at -80 °C expands the practicality of this platform for future ready-to-use applications. Together, these features make our method a compelling alternative to current technologies for applications in targeted therapy, diagnostics, and cell-based immunotherapy.